Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments
January 25, 2022 at 10:38 AM EST
One day after the U.S. Food and Drug Administration said it's halting the use of antibody drugs as COVID-19 treatments because they don't work on the highly contagious omicron variant, Pfizer and German partner BioNTech announced they are launching a trial to evaluate an omicron-based vaccine in healthy adults aged 18 to 55.
